Cargando…

The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation

Nuclear factor erythroid 2-related factor 2 (Nrf2), which regulates the expression of critical antioxidant proteins, was recently demonstrated to play a key role in cancer progression. Resistance to radiotherapy is a major obstacle in treating oral squamous cell carcinoma (OSCC). However, little is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuoka, Yuichiro, Yoshida, Ryoji, Kawahara, Kenta, Sakata, Junki, Arita, Hidetaka, Nkashima, Hikaru, Takahashi, Nozomu, Hirayama, Masatoshi, Nagata, Masashi, Hirosue, Akiyuki, Kuwahara, Yoshikazu, Fukumoto, Manabu, Toya, Ryo, Murakami, Ryuji, Nakayama, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309095/ https://www.ncbi.nlm.nih.gov/pubmed/35414650 http://dx.doi.org/10.1038/s41374-022-00776-w

Ejemplares similares

Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR‐503‐3p‐BAK axis
por: Yamana, Keisuke, et al.
Publicado: (2021)

Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma
por: Sakata, Junki, et al.
Publicado: (2020)

An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma
por: Gohara, Shunsuke, et al.
Publicado: (2022)

Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study
por: Nakashima, Hikaru, et al.
Publicado: (2016)

Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method
por: Yoshida, Ryoji, et al.
Publicado: (2020)

HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma
por: Sakata, Junki, et al.
Publicado: (2019)

Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia
por: Sakata, Junki, et al.
Publicado: (2017)

miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma
por: Kawahara, Kenta, et al.
Publicado: (2021)

IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma
por: Matsuoka, Yuichiro, et al.
Publicado: (2016)

Re-evaluating the clinical significance of serum p53 antibody levels in patients with oral cancer in Japanese clinical practice
por: Gohara, Shunsuke, et al.
Publicado: (2021)

Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy
por: Yoshida, Ryoji, et al.
Publicado: (2020)

Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration
por: Kawaguchi, Sho, et al.
Publicado: (2022)

BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene
por: Yamamoto, Tatsuro, et al.
Publicado: (2020)

Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma
por: Yoshida, R, et al.
Publicado: (2014)

Guanine nucleotide-binding protein 1 is one of the key molecules contributing to cancer cell radioresistance
por: Fukumoto, Motoi, et al.
Publicado: (2014)

The Effects of Hydrogen Peroxide and/or Radiation on the Survival of Clinically Relevant Radioresistant Cells
por: Kuwahara, Yoshikazu, et al.
Publicado: (2020)

Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors
por: Kuwahara, Yoshikazu, et al.
Publicado: (2014)

4-Methylumebelliferone Enhances Radiosensitizing Effects of Radioresistant Oral Squamous Cell Carcinoma Cells via Hyaluronan Synthase 3 Suppression
por: Hasegawa, Kazuki, et al.
Publicado: (2022)

Tumor radioresistance caused by radiation-induced changes of stem-like cell content and sub-lethal damage repair capability
por: Fukui, Roman, et al.
Publicado: (2022)

Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 “QUAD shot” regimen for incurable head and neck cancer
por: Toya, Ryo, et al.
Publicado: (2020)

The Effect of High-Dose-Rate Pulsed Radiation on the Survival of Clinically Relevant Radioresistant Cells
por: Terashima, Shingo, et al.
Publicado: (2021)

MiR-7-5p Is Involved in Ferroptosis Signaling and Radioresistance Thru the Generation of ROS in Radioresistant HeLa and SAS Cell Lines
por: Tomita, Kazuo, et al.
Publicado: (2021)

Data on the aquaporin gene expression differences among ρ(0), clinically relevant radioresistant, and the parental cells of human cervical cancer and human tongue squamous cell carcinoma
por: Takashi, Yuko, et al.
Publicado: (2018)

Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells
por: Shimura, T, et al.
Publicado: (2012)

Compositional Shift of Oral Microbiota Following Surgical Resection of Tongue Cancer
por: Kageyama, Shinya, et al.
Publicado: (2020)

Case report of surgical treatment of scoliosis caused by neurofibroma located posterior mediastinum
por: Motono, Nozomu, et al.
Publicado: (2018)

Intraoperative use of cone-beam computed tomography for the safe epidural blood patch: Technical case report
por: Kawahara, Takashi, et al.
Publicado: (2019)

Treatment of Radioresistant Cancers
por: Hendry, J. H.
Publicado: (1980)

Radioresistance of Brain Tumors
por: Kelley, Kevin, et al.
Publicado: (2016)

Exosomes in Cancer Radioresistance
por: Ni, Jie, et al.
Publicado: (2019)

Tumor microenvironment and radioresistance
por: Suwa, Tatsuya, et al.
Publicado: (2021)

Metabolic analysis of radioresistant medulloblastoma stem-like clones and potential therapeutic targets
por: Sun, Lue, et al.
Publicado: (2017)

The Glucocorticoid Receptor Regulates the ANGPTL4 Gene in a CTCF-Mediated Chromatin Context in Human Hepatic Cells
por: Nakamoto, Masafumi, et al.
Publicado: (2017)

Segmental Zoster Paresis Accompanied by Horner's Syndrome
por: Hanada, Kenta, et al.
Publicado: (2023)

Resistance to thyroid hormone accompanied by atrial fibrillation
por: Sato, Haruhiro, et al.
Publicado: (2018)

Changes in wrist joint contact area following radial shortening osteotomy for Kienböck’s disease
por: Shiota, Junki, et al.
Publicado: (2022)

Increased Artemis levels confer radioresistance to both high and low LET radiation exposures
por: Sridharan, Deepa M, et al.
Publicado: (2012)

Radioresistance in Glioblastoma and the Development of Radiosensitizers
por: Ali, Md Yousuf, et al.
Publicado: (2020)

Drivers of Radioresistance in Prostate Cancer
por: King, Liam, et al.
Publicado: (2022)

CircRNAs in Tumor Radioresistance
por: Gao, Yining, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_40bl3n2dms0eqsl9qohoqcfk0g